A joint one-day meeting between RSC Toxicology group and the UK NanoSafety Group. This meeting is looking to provide information and examples of best practice in the successful and safe commercialisation of nanomaterial based products. Those who should attend include: safety professionals, compliance managers, plant managers, general managers and those working with nanomaterials in industry or have an interest in the safe production of nanomaterial based products and services. It is also looking to attract academics who may be seeking to “go commercial” with a nano based product.
Speakers include:
Eric Mayes, Endomagnetics
"Taking a nano-based medical product to the international market"
Denis Koltsov, BREC
"Standards and their value in general and specifically for nanotechnology"
Kay Williams, Defra
"Nanomaterials – planning for EU exit"
Colin Johnston, OMCS
"Value of effective testing of nano based products"
Iseult Lynch, University of Birmingham
"Comments and conclusions re what’s safe and what’s not – past and future"
Claire Skentelbery, Nanotechnology Industries Association
“What’s happening commercially in Europe”
Karen Galea, Institute of Occupational Medicine
"NanoReg & NanoReg II: implications for industry"
Pete Gooden, Promethean Particles
“Commissioning a new plant to produce nanomaterials commercially”
